Your email has been successfully added to our mailing list.

×
0.0220440881763528 0.0420841683366733 0.0240480961923848 0.0621242484969939 0.0681362725450902 0.11623246492986 0.132264529058116 0.150300601202405
Stock impact report

Bovie Medical files 510(k) submission for new indication of J-Plasma for use in dermal resurfacing procedures [Seeking Alpha]

BOVIE MEDICAL (BVX) 
NASDAQ:AMEX Investor Relations: boviemedical.com/investor_relations
Company Research Source: Seeking Alpha
Bovie Medical (NYSEMKT: BVX )  announces a Premarket Notification 510(NYSE: K ) submission to the FDA for a new indication to market and sell J-Plasma/Renuvion for use in dermal resurfacing procedures. Regulatory clearance is expected in 2019. Click to subscribe to real-time analytics on BVX Now read: Kellogg: Is There Something Special About K? » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
BVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BVX alerts
Opt-in for
BVX alerts

from News Quantified
Opt-in for
BVX alerts

from News Quantified